Headquarters

Contact Us

(+01) 512 835 8026
3300 Duval Road
Austin, TX 78759
USA
Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

(+01) 512 835 8026
Email Us

Get a Quote Contact | FAQ's | Blog

a Q<sup>2</sup> Solutions Company

Just type and press 'enter'

Toggle menu

About Us
- About RBM
  Rules-Based Medicine (RBM), a Q² Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
- About RBM
- Newsroom
- Data Quality
  - Overview
  - RBM Technology
Biomarker Solutions
- Solutions
  - Overview
  - Assay Change Log
  If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.
  
  Learn More »
- Multiplexed Immunoassays
- Whole Blood Collection and Culture System
  Learn More »
  
  Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.
  Learn More »
Resources + Support
- Resources
- Support
How to Order
- Ordering Information
- Request Information
- Ready to Order?
  
  Great!
  
  Every order starts with a quote.
  
  Get Started

Category Archives: Blog

20 Oct 2020

TruCulture is Shown to Standardize Immune Monitoring, Again

October 20, 2020

Rules-Based Medicine

Blog, TruCulture

...

5 Oct 2020

luminex multiplexing machines for biomarker testing

Blood Test Developed for Kawasaki Disease

October 5, 2020

Rules-Based Medicine

Blog, Utilized Rules-Based Medicine's Services

...

27 Aug 2020

IFN-α, IFN-β, & IFN-λ Ultrasensitive Immunoassay Applications for Viral Pneumonia Including COVID-19

August 27, 2020

Rules-Based Medicine

Blog, COVID-19

...

28 Jul 2020

Occupational Exposure to Carbon Nanotubes/Fibers & Immune Response using TruCulture

July 28, 2020

Rules-Based Medicine

Blog, TruCulture, Utilized Rules-Based Medicine's Services

...

26 May 2020

Cerecor and Myriad Genetics Announce that Levels of Novel Cytokine, LIGHT Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study – Press Release

May 26, 2020

Rules-Based Medicine

Blog, Press

...

22 May 2020

Bibliography Updates May 2020

May 22, 2020

Rules-Based Medicine

Autoimmune and Arthritis, Blog, Cancer, Neuroscience and Neurological, Utilized Rules-Based Medicine's Services

Rules-Based Medicine's, a Q2 Solutions Company (formerly Myriad RBM) biomarker testing services and TruCulture product have been cited in over 1000 pe...

10 Mar 2020

Prognostic Lung Fibrosis Consortium (PROLIFIC) /Myriad RBM Collaborate on Pulmonary Fibrosis Biomarker Panel

March 10, 2020

Rules-Based Medicine

Blog

PROLIFIC - Idiopathic Pulmonary Fibrosis Celgene, a wholly owned subsidiary of Bristol-Myers Squibb Company, created a consortium called PROLIFIC (Pr...

1 2 3 … 20